Glimepiride 2mg + Metformin 500mg + Voglibose 0.3mg


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Side effects of Glyphase MV Tablet PRThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Glyphase MVHypoglycemia (low blood glucose level)Nausea Abdominal pain Constipation
How to use Glyphase MV Tablet PRUse it as advised by your doctor or check the label for directions before use. Glyphase MV 2/.3 Tablet PR is to be taken with food.
How Glyphase MV Tablet PR works Glyphase MV 2/.3 Tablet PR is a combination of three antidiabetic medicines:.
Unsafe: Avoid consuming alcohol with Glyphase MV 2/.3 Tablet PR as it is deemed unsafe.
Glyphase MV 2/.3 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Glyphase MV 2/.3 Tablet PR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Glyphase MV 2/.3 Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Glyphase MV 2/.3 Tablet PR may be needed. Doctor consultation is advised.Use of Glyphase MV 2/.3 Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Glyphase MV 2/.3 Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Glyphase MV 2/.3 Tablet PR may be needed. Doctor consultation is advised.Glyphase MV 2/.3 Tablet PR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.